GFC Life Science Co., Ltd

XKON:A388610 Stock Report

Market Cap: ₩43.4b

GFC Life Science Valuation

Is A388610 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A388610 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate A388610's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate A388610's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A388610?

Key metric: As A388610 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for A388610. This is calculated by dividing A388610's market cap by their current book value.
What is A388610's PB Ratio?
PB Ration/a
Book₩0
Market Cap₩43.44b

Price to Book Ratio vs Peers

How does A388610's PB Ratio compare to its peers?

The above table shows the PB ratio for A388610 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average0.6x
A024890 DAEWON Chemical
1.1xn/a₩44.2b
A900310 Coloray International Investment
0.1xn/a₩38.4b
1xn/a₩43.4b
0.4xn/a₩44.0b
A388610 GFC Life Science
n/an/a₩43.4b

Price-To-Book vs Peers: Insufficient data to calculate A388610's Price-To-Book Ratio vs. peers for valuation analysis.


Price to Book Ratio vs Industry

How does A388610's PB Ratio compare vs other companies in the KR Chemicals Industry?

2 CompaniesPrice / BookEstimated GrowthMarket Cap
A388610 is unprofitableIndustry Avg. 0.6xNo. of Companies27PB00.61.21.82.43+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: Insufficient data to calculate A388610's Price-To-Book Ratio vs. industry for valuation analysis.


Price to Book Ratio vs Fair Ratio

What is A388610's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A388610 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ration/a
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate A388610's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies